How We Classify and Present Products
A compound reference, a supplied product and a regulatory classification answer different questions. Knockout Labs’ compound pages explain scientific entities; product pages describe the catalogue item and available evidence. Neither page type, by itself, proves the legal status or suitability of a particular supply.
Define the material before its presentation
A product-specific assessment needs the exact identity, form, composition, labelled quantity and container. Similar names can cover different modifications or preparations. The product-specification guide explains which fields distinguish a reference molecule from the material offered for sale.
Keep supplier declarations separate from measured lot results. A declared identity or purity threshold is not the same as an analytical observation, and an analytical observation is not a regulatory decision. Where the supporting dossier is incomplete, the missing field should remain explicit in the internal review.
Consider the whole presentation
The MHRA assesses borderline products case by case, taking account of composition, presentation and purpose. A “research use only” statement does not replace that assessment. [1]
For a website, the practical review therefore extends beyond one disclaimer. Product descriptions, photographs, category labels, metadata, FAQs and associated communications should tell a consistent story. An informational paper summary must not become an unsupported promise about the item sold beside it.
Keep product information within its evidence
| Information | Appropriate supporting record |
|---|---|
| Identity and chemical form | Product specification and suitable identity evidence |
| Labelled quantity | Defined fill basis and any applicable quantitative evidence |
| Purity or other quality attribute | Matching result, method, reporting basis and lot connection |
| Storage or transport condition | Instructions and evidence applicable to the material and presentation |
| Commercial or regulatory status | A documented product-specific decision and appropriate advice where required |
Terms such as pharmaceutical grade, GMP, sterile and cold-chain require their own support. They are not interchangeable quality labels. A general explanation of a test does not show that the test was performed on a particular product or lot.
Responsibility and changes
The Director holds responsibility for classification, content and regulatory decisions within Knockout Labs. This page does not assert that every SKU has a completed written determination or a regulator’s endorsement. A catalogue listing should not be read as that evidence.
A changed identity, formulation, claim or intended presentation may require a fresh assessment. The review should identify the affected product, the reason for the change and the representations that need correction. Actual ordering restrictions remain a separate business and regulatory decision; this explanatory page does not change checkout availability.
Read buyer eligibility, claims we do not make and the compliance hub. For questions about the evidence behind a specific item, use the product details and technical support, rather than inferring a status from a general compound description.
The dated UK regulation and advertising monitor records source updates and distinguishes them from product-specific decisions still requiring review.
Supporting checks
| Resource | Why open it |
|---|---|
| Comparing UK Research Peptide Suppliers: An Evidence Framework | Compare suppliers using the same evidence criteria. |
| About Knockout Labs | Read the company role and its confirmed operational scope. |
Sources and scope
- MHRA Guidance Note 8: A guide to what is a medicinal productCase-by-case classification; presentation context; cover date distinct from file name Access: Official source opened; relevant passage read Limits: Not a definitive statement of law or product-specific decision; no qualified review claimed
UK Product Classification and Website Presentation
A product's website presentation forms part of the classification question. Review the actual material and the complete message a buyer encounters, including implied claims. A general regulatory explanation cannot determine the status of a particular catalogue item.
What the official guidance addresses
MHRA's borderline-products guidance identifies claims, ingredient properties, intended purpose and public presentation among the factors it considers. Guidance Note 8 provides the fuller framework. [2] [1]
Review the page in its purchasing context
| Surface | Review question |
|---|---|
| Product title and description | Does the wording accurately identify the material and stay within its approved scope? |
| Images and captions | What use or outcome do they imply? |
| Research summaries | Are model, preparation and endpoint limits retained? |
| Category and internal links | Does the route create a broader implied claim? |
| Reviews and supporting content | Does the surrounding presentation contradict the stated boundary? |
| Purchase flow | Are the actual supply conditions represented accurately? |
This matrix is an editorial review aid. It does not declare that checking the boxes makes a product lawful.
Keep scientific evidence and legal scope separate
A paper may support a statement about an experimental molecule without supporting a claim about the supplied product. A well-supported scientific paragraph can still require a separate presentation review in its commercial setting.
Likewise, a disclaimer does not resolve an unidentified compound or replace a product-specific decision. Use names and identifiers to establish what is being discussed before reviewing how it is presented.
Record the decision
The business record should identify the product and form, reviewed content, decision owner, date, conditions and unresolved questions. If identity or presentation changes, assess whether the earlier decision still covers it.
The classification policy and claims boundary own the site's operating position. This explainer remains subject to qualified review and supplies no blanket conclusion for the catalogue.
Supporting checks
| Resource | Why open it |
|---|---|
| Research Use and Buyer Eligibility Policy | Read the UK research-buyer and manual-order-review conditions. |
| Compliance | Find the policy owner for eligibility, classification or claims. |
Sources and scope
- MHRA Guidance Note 8: A guide to what is a medicinal productCase-by-case classification; presentation context; cover date distinct from file name Access: Official source opened; relevant passage read Limits: Not a definitive statement of law or product-specific decision; no qualified review claimed
- MHRA: Borderline products: how to tell if your product is a medicine12 May 2026 guidance replacement; 2 July 2026 statistics update; assessment factors Access: Official source opened; relevant passage read Limits: No claim that an update note proves a new law or exact substantive amendment